Increased risk for postoperative hemorrhage after lintracranial surgery in patients with decreased factor XIII activity -: Implications of a prospective study

被引:139
作者
Gerlach, R
Tölle, F
Raabe, A
Zimmermann, M
Siegemund, A
Seifert, V
机构
[1] Univ Frankfurt, Dept Neurosurg, D-60528 Frankfurt, Germany
[2] Univ Leipzig, Dept Med, Leipzig, Germany
关键词
coagulation; cramotomy; factor XIII; factor XIII deficiency; fibrinolysis; hematoma; neurosurgical procedures;
D O I
10.1161/01.STR.0000017219.83330.FF
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The functional integrity of the hemostatic system is a prerequisite for the safe performance of neurosurgical procedures. To monitor the individual coagulation capacity of each patient, standard tests are effective to detect deficiencies involving the generation of fibrin. However, fibrin clot strength depends primarily on coagulation factor XIII, which cross-links fibrin monomers and enhances clot resistance against fibrinolysis. Therefore, factor XIII is functionally involved in both the hemostatic and fibrinolytic systems. The objective of this prospective study was to determine the incidence and clinical relevance of perioperative decreased factor XIII with respect to standard coagulation parameters and the occurrence of postoperative hematoma. Methods-In 876 patients, 910 neurosurgical procedures were performed. Prothrombin time (PT), partial thromboplastin time (PTT), platelet count, fibrinogen, and factor XIII were tested in each patient preoperatively and postoperatively. Results-Postoperative intracranial hematoma (defined as requiring surgical evacuation) occurred after 39 (4.3%) of 910 Z, surgical procedures. Patients with postoperative hematoma had significantly lower factor XIII and fibrinogen levels preoperatively and postoperatively than patients without hematoma. In patients with postoperative hematoma, PT and platelets differed significantly only postoperatively, whereas PTT was different neither preoperatively nor postoperatively. Of the 39 patients with a postoperative hematoma, 13 (33.3%) had a postoperative factor XIII <60% compared with 61 (7%) of 867 patients without hematoma (P<0.01, Fisher's exact test). The relative risk of developing a postoperative hematoma is therefore increased 6.4-fold in patients with postoperative factor XIII <60%. The risk is increased 12-fold in patients who additionally have postoperative decreased fibrinogen levels (< 1.5 g/L) and 9-fold in patients with platelet count < 150 x 10(9)/L and factor XIII <60%. Conclusions-This is the first prospective study that demonstrates the association of decreased perioperative factor XIII with an increased risk of postoperative hematoma in neurosurgical patients. The risk is further increased in those patients with low factor XIII and additional abnormalities of fibrinogen, PT, platelets, and PTT. Factor XIII testing and specific replacement, as accepted for other clotting factors, may reduce the risk of postoperative hematoma.
引用
收藏
页码:1618 / 1623
页数:6
相关论文
共 37 条
[1]   PREOPERATIVE ASPIRIN THERAPY AND REOPERATION FOR BLEEDING AFTER CORONARY-ARTERY BYPASS-SURGERY [J].
BASHEIN, G ;
NESSLY, ML ;
RICE, AL ;
COUNTS, RB ;
MISBACH, GA .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (01) :89-93
[2]   LIFE-THREATENING HEMORRHAGIC DIATHESIS DUE TO DISSEMINATED INTRAVASCULAR COAGULATION DURING ELECTIVE BRAIN-TUMOR SURGERY [J].
BERGER, MM ;
RAVUSSIN, P ;
VIELLE, G ;
FANKHAUSER, H .
JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 1995, 7 (01) :26-29
[3]   RECURRENT HEMATOMAS FOLLOWING CRANIOTOMY FOR TRAUMATIC INTRACRANIAL MASS [J].
BULLOCK, R ;
HANNEMANN, CO ;
MURRAY, L ;
TEASDALE, GM .
JOURNAL OF NEUROSURGERY, 1990, 72 (01) :9-14
[4]  
BURCHARDT P, 1978, AKTUEL UROL, V9, P29
[5]   Platelets and phospholipids in tissue factor-initiated thrombin generation [J].
Butenas, S ;
Branda, RF ;
van't Veer, C ;
Cawthern, KM ;
Mann, KG .
THROMBOSIS AND HAEMOSTASIS, 2001, 86 (02) :660-667
[6]   Factor XIII Val 34 Leu - A novel association with primary intracerebral hemorrhage [J].
Catto, AJ ;
Kohler, HP ;
Bannan, S ;
Stickland, M ;
Carter, A ;
Grant, PJ .
STROKE, 1998, 29 (04) :813-816
[7]   Factor XIIIA and clot strength after cardiopulmonary bypass [J].
Chandler, WL ;
Patel, MA ;
Gravelle, L ;
Soltow, LO ;
Lewis, K ;
Bishop, PD ;
Spiess, BD .
BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (02) :101-108
[8]   Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage [J].
Corral, J ;
Iniesta, JA ;
González-Conejero, R ;
Villalón, M ;
Vicente, V .
BLOOD, 2001, 97 (10) :2979-2982
[9]   Vinorelbine: A new promising drug in Hodgkin's disease [J].
Devizzi, L ;
Santoro, A ;
Bonfante, V ;
Viviani, S ;
Bonadonna, G .
LEUKEMIA & LYMPHOMA, 1996, 22 (5-6) :409-414
[10]   A HITHERTO UNDESCRIBED CONGENITAL HAEMORRHAGIC DIATHESIS PROBABLY DUE TO FIBRIN STABILIZING FACTOR DEFICIENCY [J].
DUCKERT, F ;
JUNG, E ;
SHMERLING, DH .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1960, 5 (02) :179-186